Search Tag: CVD

Executive Health Management

The Sex and Gender Influence on Hypertension

2019 02 Oct

Despite underlying physiological differences and a different set of risk factors, diagnosis, management, and treatment strategies for hypertension do not account for sex and gender variances. Evidence-based guidelines for hypertension treatment from clinical trials are similar between males and females; however, most of these trials do not... Read more

Executive Health Management

New Management Pathways in Cardiovascular Risk Factors

2019 02 Oct

Summary: A presentation of a case study in light of the updated ESC guidelines on lipid control and new guidelines on diabetes and cardiovascular disease. Several new guidelines were released at the European Society of Cardiology (ESC) Congress in Paris, France. These included updated guidelines on lipid control and new guidelines... Read more

Cardiology Management

All-in-One Pill Reduces Blood Pressure

2019 23 Sep

A combination pill containing three medications used to tackle high blood pressure and one used for high cholesterol was found to reduce cardiovascular disease (CVD) risk by 25%.   The study, published in the New England Journal of Medicine (NEJM), assessed the effectiveness of atorvastatin, amlodipine, losartan and hydrochlorothiazide in polypill... Read more

Health Management

Volume 19 - Issue 4, 2019

2019 26 Aug

Change content default value Read more

Executive Health Management

The Future of Cardiovascular Disease Treatment and Management

2019 26 Aug

Arthur M. Feldman, MD, PhD, Laura H. Carnell Professor of Medicine at the Lewis Katz School of Medicine at Temple University, has been recognised with the 2019 Distinguished Scientist Award-Basic Domain by the American College of Cardiology. Prof. Feldman has received this honour due to his contribution towards improving cardiovascular health and... Read more

Executive Health Management

Cardiology and mHealth – Rethink About Monitoring

2019 26 Aug

Summary: Overview about the value of mHealth in cardiology exemplified by some promising tools that for sure will change the way cardiology is practiced, especially in the management of rhythm disturbances like atrial fibrillation.   Where Are We Now?   Nowadays, there is a lot of hype about the role of wearables and mobile health (mHealth)... Read more

Executive Health Management

Sex & Gender Impacts in Cardiovascular Disease: A “Typical” Presentation of Cardiovascular Disease?

2019 26 Aug

Summary: Differences in sex and gender may account for gaps in treatment and prevention of cardiovascular disease, but at the same time, it also gives the opportunity for personalised sex and gender-specific medicine.   Typical presentations in medicine are defined in ways that health care professionals can draw on past experiences and education... Read more

Executive Health Management

Cardiovascular Disease Prevention 2019: Quo Vadis?

2019 26 Aug

Summary: Cardiovascular disease prevention strategies in 2019 remain a major healthcare issue, requiring an individualised approach for diagnostic and therapeutic decision making.   Introduction   Since investigators from the Framingham Heart Study first confirmed the existence and importance of cardiovascular disease (CVD) risk factors in... Read more

Executive Health Management

Nuclear Cardiology: Molecular Insights into the Heart

2019 26 Aug

Summary: Nuclear cardiology is a promising field located between research, imaging, and patient care. Through close interdisciplinary cooperation, a variety of cardiovascular diseases (eg coronary artery, inflammatory and infiltrative cardiac diseases) can not only be investigated, but also efficiently treated in daily clinical routine.    What... Read more

Executive Health Management

Hypertension – Prevention is Better Than Cure

2019 26 Aug

How can we get the most common, costly, and modifiable cardiovascular risk factor under control?     Cardiovascular disease (CVD) is the number one cause of death with an upward trend beyond 30% and a tripling in costs between 2010 and 2030, placing a significant economic burden on public healthcare services. 1,2,3 The most common risk factor... Read more